Rubella seroprevalence using residual samples from the South African measles surveillance program: a cross-sectional analytic study

Rubella seroprevalence using residual samples from the South African measles surveillance program: a cross-sectional analytic study

Introduction: South Africa is yet to introduce rubella-containing vaccines (RCV) into its routine immunization schedule. Selecting the target population when introducing RCV should take into account the ages of susceptible individuals in the population. We aimed to determine the seroprevalence of an...

Full description

Bibliographic Details
Main Authors: N. V. Motaze, L. Makhathini, S. B. Smit, C. G. Adu-Gyamfi, M. Fortuin, C. S. Wiysonge, S. M. Suchard
Format: Article
Language:English
Published: Taylor & Francis Group 2020-11-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
rubella
serosurvey
immunity
antibodies
sero-epidemiology
rubella-containing vaccines
seroprevalence
Online Access:http://dx.doi.org/10.1080/21645515.2020.1738834

Internet

http://dx.doi.org/10.1080/21645515.2020.1738834

Similar Items